[1] Younossi ZM, Koenig AB, Abdelatif D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016, 64: 73-84.
[2] Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L,et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology, 2015, 149: 367-378.
[3] Henao-Mejia J, Elinav E, Jin C,et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature, 2012, 482: 179-185.
[4] Schuppan D, Afdhal NH. Liver cirrhosis. Lancet, 2008, 371: 838-851.
[5] de Mello VD, Matte A, Perfilyev A,et al. Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action. Epigenetics, 2017, 12: 287-295. |
